Drug Profile
Dihydrexidine
Alternative Names: IP 202Latest Information Update: 18 Jun 1997
Price :
$50
*
At a glance
- Originator Purdue University
- Class Phenanthridines; Small molecules
- Mechanism of Action Dopamine D1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Parkinson's disease
Most Recent Events
- 18 Jun 1997 Discontinued-I for Parkinson's disease in USA (Unknown route)
- 16 Jun 1995 Phase-I clinical trials for Parkinson's disease in USA (Unknown route)